Cat.No. : VNV-027
Storage: -80°C Shipping: Dry ice
| Cat. No. | VNV-027 |
| Description | Wild type respiratory syncytial virus A (RSV-A) particles which are inactivated by heat treatment. This product is intended for research use only. |
| Shipping | Dry ice |
| Storage | -80°C |
| Creative Biogene ensures high-quality lentivirus particles by optimizing and standardizing production protocols and performing stringent quality control (QC). The specific QC experiments performed vary between lentivirus particle lots. | |
| Mycoplasma | Creative Biogene routinely tests for mycoplasma contamination using a mycoplasma detection kit. Cell lines are maintained for approximately 20 passages before being discarded and replaced with a new vial of early passage cells. Approximately 2 weeks after thawing, cell culture supernatants are tested for mycoplasma contamination. Creative Biogene ensures that lentiviral products are free of mycoplasma contamination. |
| Purity | Creative Biogene evaluates the level of impurities, such as residual host cell DNA or proteins, in prepared lentiviral vectors to ensure they meet quality standards. |
| Sterility | The lentiviral samples were inoculated into cell culture medium for about 5 days and the growth of bacteria and fungi was tested. Creative Biogene ensures that the lentiviral products are free of microbial contamination. |
| Transducibility | Upon requirement, Creative Biogene can perform in vitro or in vivo transduction assays to evaluate the ability of lentivirus to deliver genetic material into target cells, and assess gene expression and functional activities. |
| Proviral Identity Confirmation | All Creative Biogene lentiviral vectors are confirmed to have correctly integrated provirus using PCR. This test involves transducing cells with serial dilutions of the lentiviral vector, harvesting the cells a few days later, and isolating genomic DNA. This DNA is then used as a template to amplify a portion of the expected lentiviral insert. |
A: Wild-type respiratory syncytial virus (RSV) A and RSV B are two major subtypes of the RSV virus, and they differ in various aspects, including molecular characteristics, epidemiology, and clinical manifestations.
A: Wild-type Respiratory Syncytial Virus A can be used in various research fields, including virology, immunology, and vaccine development. Researchers can study the virus's pathogenesis, host immune response, and develop potential therapeutic interventions or vaccines using these products.
A: Respiratory syncytial virus (RSV), also known as human respiratory syncytial virus (hRSV) and human orthopneumovirus, is a common contagious virus that causes respiratory infections.
A: The genome of the Respiratory Syncytial Virus is linear and approximately 15,000 nucleotides in length. It has 10 genes encoding for 11 proteins.
A: Respiratory Syncytial Virus (RSV) is a medium-sized (~150 nm) enveloped virus. Although many particles are spherical, filamentous particles have also been identified. The genome is located within a helical nucleocapsid and is surrounded by matrix proteins and an envelope containing viral glycoproteins.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
I have been using Wild-Type Respiratory Syncytial Virus A for vaccine development, and I am extremely pleased with its performance. The virus has demonstrated strong infectivity, allowing us to accurately assess the efficacy of our vaccine candidates.
The quality of Wild-Type Respiratory Syncytial Virus A is exceptional. We have been using this strain for multiple studies, and the results have been consistently reliable and reproducible.
Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.
Our promise to you:
Guaranteed product quality, expert customer support.
24x7 CUSTOMER SERVICE
CONTACT US TO ORDER
Copyright © Creative Biogene. All rights reserved.
